Literature DB >> 15246193

Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?

Federico Rea1, Giuseppe Marulli, Donatella Callegaro, Andrea Zuin, Tobia Gobbi, Monica Loy, Francesco Sartori.   

Abstract

STUDY
OBJECTIVES: Accurate TNM staging is the basis to evaluate prognosis and to plan treatment of patients with non-small cell lung cancer. Exact definition of N status is fundamental and the boundary line between N1 and N2 stations is one of the most controversial issue. Purpose of this study is to evaluate the prognostic significance of main bronchus nodes, that we classified as station number 10 (N1).
METHODS: We reviewed retrospectively lymph node patterns and survival of 175 patients with N1 and 154 with N2 disease, that underwent surgical resection with hilar and mediastinal lymphadenectomy from January 1990 to December 2000. These two groups were subdivided in N1 without station number 10 involvement (N1-, n = 144), N1 with station number 10 involvement (N1+, n = 31), N2 single station (N2s, n = 107) and N2 multiple stations (N2m, n = 47), respectively. A univariate and multivariate analysis of prognostic factors predicting survival has been performed.
RESULTS: Overall 5-year survival rate for 175 N1 patients and 154 N2 patients was 42 and 13%, respectively and the difference was statistically significant (P < 0.001). The prognosis between N1-, N1+, N2 was compared: 5-year survival rate was 44, 31 and 13%, respectively and the difference reached a statistical value between N1+ and N2 (P < 0.05), but not between N1- and N1+. When the comparison was made with N1-, N1+, N2s and N2m, the difference was significant between N1- and N2s (P = 0.0003), between N1+ and N2m (P = 0.0001), but not between N1+ and N2s.
CONCLUSIONS: The aim of a uniform anatomical and clinical classification of nodal stations has not been thoroughly achieved, particularly regarding the boundary line between N1 and N2. Our study points out that the involvement of main bronchial nodes has a prognostic significance similar to that of N2 single station and should be considered as an early N2 disease.

Entities:  

Mesh:

Year:  2004        PMID: 15246193     DOI: 10.1016/j.lungcan.2004.01.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  3 in total

1.  Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.

Authors:  Hajime Maeda; Shimao Fukai; Akihide Matsumura; Osamu Kawashima; Takehiro Watanabe; Takeshi Yamanda; Kan Okabayashi; Yuka Fujita; Atsuhisa Tamura; Masaaki Kawahara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-11-12

2.  Validation of the Proposed cN2 Subclassification in the Eighth Edition of the IASLC Staging System: A Prospective Phase II Multicenter Study.

Authors:  Jiro Abe; Yuji Matsumura; Satoshi Shiono; Masaya Aoki; Masami Sato; Hiroyuki Oura; Hirohisa Kato; Muneo Minowa; Hiroyuki Oizumi; Motoyasu Sagawa; Akira Sakurada; Yoshinori Okada
Journal:  JTO Clin Res Rep       Date:  2020-02-27

3.  High dose involved field radiation therapy as salvage for loco-regional recurrence of non-small cell lung cancer.

Authors:  Sun Hyun Bae; Yong Chan Ahn; Heerim Nam; Hee Chul Park; Hong Ryull Pyo; Young Mog Shim; Jhingook Kim; Kwhanmien Kim; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park
Journal:  Yonsei Med J       Date:  2012-11-01       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.